Fundus disease is one of the important disciplines in the field of ophthalmology, and the prevention and treatment of fundus disease is a hot topic of ophthalmology that is of universal concern. Recently, the inaugural session of the Purui Ophthalmology Fundus Disease Group and the Symposium on the Development Plan of Fundus Disease Discipline were held at Nanchang Purui Ophthalmology Hospital. At the meeting, Sun Qiang, General Manager of Purui Ophthalmology, stated that the company actively promotes a long-term strategy of technology leading and innovation driven. The high-quality development of the ophthalmology discipline is of great significance for improving the hospital's scientific research academic ability and brand reputation. He hopes that the new ophthalmology group can fully utilize the advantages of expert technology, promote the construction of an integrated innovation platform and talent development system for medical education and research, and further expand the scale of discipline development Enhance the strength of the discipline and provide more convenient, high-quality, and efficient diagnosis and treatment services for patients with fundus diseases. Yue Yiying, Medical Director of Purui Ophthalmology, pointed out that the Ophthalmology Group should play a positive role in promoting the standardization and treatment of fundus diseases, driving the common growth of young ophthalmologists, promoting the construction of a talent team in the discipline, and continuously improving the level of medical quality and diagnosis and treatment service capabilities. Liu Hongshan, the research director of Purui Ophthalmology, emphasized that the construction level of the ophthalmic fundus disease discipline is an important reflection of the medical research ability of ophthalmic hospitals. He hopes that the new ophthalmic group can fully leverage its professional advantages, promote the standardization of diagnosis and treatment processes, promote clinical and scientific research innovation and development, and drive the overall level of the ophthalmic fundus disease discipline construction of Purui Ophthalmology to improve. The meeting elected the 2023 Presley Ophthalmology Fundus Ophthalmology Group Committee through secret ballot. Wang Fang, the general director of Purui Ophthalmology in Shanghai, was elected as the head of the ophthalmology group. Yang Haijun, the director of Nanchang Purui Ophthalmology Hospital and the leader of the previous ophthalmology group, was elected as the honorary head of the group. Teng Yan, the director of Harbin Purui Ophthalmology Hospital, Yu Qiang, the director of Dongguan Guangming Ophthalmology Hospital and the general director of Purui Ophthalmology Greater Bay Area Cai Na, the president of Shenyang Purui Ophthalmology Hospital, and Xu Zejun, the vice president of Wuhan Purui Ophthalmology Hospital, were respectively elected as the deputy leaders of the study group. Wang Fang, the leader of the new Prestige Ophthalmology Fundus Disease Group, delivered a speech titled "Development Goals and Three Year Plan for Prestige Ophthalmology Fundus Disease Profession (Discussion Draft)". Wang Fang stated that the development goal of the Purui Ophthalmology Fundus Disease discipline in the next three years is to build it into a characteristic specialty that meets the first-class standards in China. She firmly believes that with the joint efforts of all experts, making full use of the company's various advantageous resources, strictly implementing established plans, and doing every task well, this goal will definitely be achieved. The members of the Fundus Ophthalmology Group freely discussed and exchanged in-depth views on the current situation and future development of the Fundus Ophthalmology specialty at Purui Ophthalmology, and reached several consensus: 1. Establish a "Pilot Flight Expert Database" to cultivate professional talents through a combination of "inviting in" and "going out" methods, and improve the diagnostic and treatment capabilities of ophthalmology specialty doctors at each hospital; 2. Promote the standardization of diagnosis and treatment services for fundus diseases, activate unified medical and surgical record templates for fundus disease specialties, revise preoperative love letters, critical value and treatment recommendations, etc; 3. Regularly hold standardized training courses on Clinical pathway and diagnosis and treatment process as planned; 4. Actively organize Academic conference and international exchange activities; 5. Carry out 1-2 multicenter clinical research projects within 3 years. The meeting believes that the Prey Ophthalmology Fundus Ophthalmology Group should shoulder the heavy responsibility of disciplinary construction,